Akèy › Karsinòm selil skuamèz tèt ak kou › Kalifòni › San Diego
Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan San Diego, CA
14 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi lwen
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Ap rekriteFaz 2/3
- Site #0107, La Jolla · 11 mi lwen
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Ap rekriteFaz 1
- ALX Center 9, La Jolla · 11 mi lwen
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Ap rekriteFaz 3
- Scripps Health, La Jolla · 11 mi lwen
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Ap rekriteFaz 3
- University of California at San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Intratumoral N17350 in Advanced Solid Tumors
Ap rekriteFaz 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
- University of California, San Diego, La Jolla · 11 mi lwen
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Ap rekriteFaz 2/3
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Sharp Healthcare, San Diego
- UCSD, La Jolla · 11 mi lwen
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi lwen
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Ap rekriteFaz 1
- Moores Cancer Center UC San Diego Health, La Jolla · 11 mi lwen
A Beta-only IL-2 ImmunoTherapY Study
Ap rekriteFaz 1/2
- Sharp Memorial Hospital, San Diego
Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil
- Houston, TX47 etid
- Los Angeles, CA42 etid
- Boston, MA40 etid
- Nashville, TN39 etid
- New York City, NY39 etid
- St. Louis, MO28 etid
- Arlington, VA26 etid
- Philadelphia, PA26 etid
- Chicago, IL26 etid
- Atlanta, GA24 etid
- San Antonio, TX22 etid
- Pittsburgh, PA22 etid
Lòt etid nan San Diego
- Kansè Poumon ki pa ti selil48 etid
- Kansè nan tete41 etid
- Kansè (tout kalite)32 etid
- Kansè pwostat31 etid
- Kansè Metastatik30 etid
- Kansè kolorektal25 etid
- Kansè ovè24 etid
- Kansè pankreyas24 etid
- Kansè poumon23 etid
- Obèsite23 etid
- Ensifizyans kadyak23 etid
- Depresyon21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.